|
National Alliance of Methadone Advocates
The President’s Office Joycelyn Woods Executive Report |
|
DRAFT New York State Regulations, Page 4 of 5
|
Similar Posts
42 Code of Federal Regulations Part 8 Opioid Treatment Programs Certification
ByAdminAdmin 02/28/2022Title 42–Public Health CHAPTER I–PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES PART 8–CERTIFICATION OF OPIOID TREATMENT PROGRAMS Subpart A–Accreditation Sec. 8.1 Scope. 8.2 Definitions. 8.3 Application for approval as an accreditation body. 8.4 Accreditation body responsibilities. 8.5 Periodic evaluation of accreditation bodies. 8.6 Withdrawal of approval of accreditation bodies. Subpart B–Certification and Treatment Standards 8.11 Opioid treatment program certification. 8.12 Federal…
Pre-conference Meeting Sunday, October 7th Unifying the Treatment Community
ByAdminAdmin 01/11/2022Unifying the Treatment Community This special pre-conference meeting is divided into two sessions – a morning and afternoon session. These sessions have been developed by the Advocacy Coalition: National Alliance of Methadone Advocates (NAMA), Advocates for Recovery through Medicine (ARM), Advocates For the Integration of Recovery and Methadone (AFIRM), Virginia Alliance of Methadone Advocates (VAMA),…
FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction Drug
ByAdminAdmin 03/17/2023FDA Talk Paper April 20, 2001 T01-15 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA The FDA is strengthening warnings to physicians about serious cardiac adverse events associated with Orlaam (levomethadyl acetate HC), a drug for opiate addiction treatment. FDA has changed the Orlaam labeling to increase the strength of the warnings and to…
AMTA Conference Comittee
ByAdminAdmin 06/15/2023Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Committee Chair John Finger Committee Members Assistant to the Chair, Michael Garrett Co-chair, Alice Diorio Committee James DePasquale Becky Duarte Barbara Finger Carlos Franco Greg Keller Howard Lotsof Judith Ostergard Carmen Pearman Diane Seaman Joycelyn Woods NAMA Events and Activities Exhibition Booth Booth Manager:…
The National Methadone Conference-3
ByAdminAdmin 09/15/2022American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Workshop April 15, 2003 Medication – Assisted Treatment in Different Practice Settings: Patients’ Perspectives Joycelyn Woods, National Alliance of Methadone Advocates, Facilitator NAMA representativees will discuss the administration of methadone in a variety of settings. Topics will include the patients’…
Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award!
ByAdminAdmin 03/06/2023Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! NAMA Recovery AATOD Lane Holden Award May 1, 2022 | 0 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive…